Radiopharm Theranostics Ltd
Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.
RADX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US75041J1016
- LEI:
- Country:
- United States of America
- Address:
- LEVEL 3, 62 LYGON STREET, 3053 CARLTON VIC
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Radiopharm Theranostics is a clinical-stage biotechnology company developing a portfolio of first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer. The company is advancing a diverse pipeline based on proprietary platforms—including antibodies, nanobodies, peptides, and small molecules—to address significant unmet needs in oncology. Its strategy focuses on pioneering novel oncology targets, distinguishing itself from therapies aimed at more established pathways. Key differentiators include strategic collaborations, such as a joint venture with MD Anderson Cancer Center, and a focus on operational excellence and reliable isotope supply chains.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Radiopharm Theranostics Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Radiopharm Theranostics Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Radiopharm Theranostics Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
